Search Results - "Ribi, Karin"

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer by Partridge, Ann H., Niman, Samuel M., Ruggeri, Monica, Peccatori, Fedro A., Azim, Hatem A., Colleoni, Marco, Saura, Cristina, Shimizu, Chikako, Sætersdal, Anna B., Kroep, Judith R., Mailliez, Audrey, Warner, Ellen, Borges, Virginia F., Amant, Frédéric, Gombos, Andrea, Kataoka, Akemi, Rousset-Jablonski, Christine, Borstnar, Simona, Takei, Junko, Lee, Jeong E., Walshe, Janice M., Ruíz-Borrego, Manuel, Moore, Halle C.F., Saunders, Christobel, Bjelic-Radisic, Vesna, Susnjar, Snezana, Cardoso, Fatima, Smith, Karen L., Ferreiro, Teresa, Ribi, Karin, Ruddy, Kathryn, Kammler, Roswitha, El-Abed, Sarra, Viale, Giuseppe, Piccart, Martine, Korde, Larissa A., Goldhirsch, Aron, Gelber, Richard D., Pagani, Olivia

“…In women with previous breast cancer who temporarily discontinued adjuvant endocrine therapy to attempt pregnancy, the frequency of breast cancer events was…”
Get full text

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer by Pagani, Olivia, Regan, Meredith M, Walley, Barbara A, Fleming, Gini F, Colleoni, Marco, Láng, István, Gomez, Henry L, Tondini, Carlo, Burstein, Harold J, Perez, Edith A, Ciruelos, Eva, Stearns, Vered, Bonnefoi, Hervé R, Martino, Silvana, Geyer, Charles E, Pinotti, Graziella, Puglisi, Fabio, Crivellari, Diana, Ruhstaller, Thomas, Winer, Eric P, Rabaglio-Poretti, Manuela, Maibach, Rudolf, Ruepp, Barbara, Giobbie-Hurder, Anita, Price, Karen N, Bernhard, Jürg, Luo, Weixiu, Ribi, Karin, Viale, Giuseppe, Coates, Alan S, Gelber, Richard D, Goldhirsch, Aron, Francis, Prudence A

“…Aromatase inhibitors are somewhat more effective than tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer. This benefit was extended…”
Get full text

Experiences of people affected by cancer during the outbreak of the COVID-19 pandemic: an exploratory qualitative analysis of public online forums by Colomer-Lahiguera, Sara, Ribi, Karin, Dunnack, Hayley J., Cooley, Mary E., Hammer, Marilyn J., Miaskowski, Christine, Eicher, Manuela

“…Purpose Studies focusing on patients with and survivors of cancer during the COVID-19 pandemic highlight unique psychological and behavioral challenges. These…”
Get full text

Meeting the Decision-Making Preferences of Patients With Breast Cancer in Oncology Consultations: Impact on Decision-Related Outcomes by BROWN, Richard, BUTOW, Phyllis, WILSON-GENDERSON, Maureen, BERNHARD, Juerg, RIBI, Karin, JURASKOVA, Ilona

“…To investigate how involvement preferences of patients with breast cancer change during the treatment decision-making process and determine the impact of…”
Get full text

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials by Saha, Poornima, Regan, Meredith M, Pagani, Olivia, Francis, Prudence A, Walley, Barbara A, Ribi, Karin, Bernhard, Jürg, Luo, Weixiu, Gómez, Henry L, Burstein, Harold J, Parmar, Vani, Torres, Roberto, Stewart, Josephine, Bellet, Meritxell, Perelló, Antonia, Dane, Faysal, Moreira, Antonio, Vorobiof, Daniel, Nottage, Michelle, Price, Karen N, Coates, Alan S, Goldhirsch, Aron, Gelber, Richard D, Colleoni, Marco, Fleming, Gini F

“…Purpose To describe benefits and toxicities of adjuvant endocrine therapies in women younger than 35 years with breast cancer (n = 582) enrolled in the…”
Get full text

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial by Henke, Guido, Knauer, Michael, Ribi, Karin, Hayoz, Stefanie, Gérard, Marie-Aline, Ruhstaller, Thomas, Zwahlen, Daniel R, Muenst, Simone, Ackerknecht, Markus, Hawle, Hanne, Fitzal, Florian, Gnant, Michael, Mátrai, Zoltan, Ballardini, Bettina, Gyr, Andreas, Kurzeder, Christian, Weber, Walter P

“…Complete lymph node removal through conventional axillary dissection (ALND) has been standard treatment for breast cancer patients for almost a century. In the…”
Get full text

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial by Stahel, Rolf A, Prof, Riesterer, Oliver, MD, Xyrafas, Alexandros, Opitz, Isabelle, MD, Beyeler, Michael, PhD, Ochsenbein, Adrian, Prof, Früh, Martin, MD, Cathomas, Richard, MD, Nackaerts, Kristiaan, MD, Peters, Solange, MD, Mamot, Christoph, MD, Zippelius, Alfred, Prof, Mordasini, Carlo, MD, Caspar, Clemens B, MD, Eckhardt, Katrin, PhD, Schmid, Ralph A, Prof, Aebersold, Daniel M, Prof, Gautschi, Oliver, MD, Nagel, Wolfgang, MD, Töpfer, Michael, MD, Krayenbuehl, Jerome, PhD, Ribi, Karin, PhD, Ciernik, llja F, MD, Weder, Walter, Prof

“…Summary Background Postoperative hemithoracic radiotherapy has been used to treat malignant pleural mesothelioma, but it has not been assessed in a randomised…”
Get full text

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials by Bernhard, Jürg, Dr, Luo, Weixiu, MD, Ribi, Karin, PhD, Colleoni, Marco, MD, Burstein, Harold J, MD, Tondini, Carlo, MD, Pinotti, Graziella, MD, Spazzapan, Simon, MD, Ruhstaller, Thomas, MD, Puglisi, Fabio, MD, Pavesi, Lorenzo, MD, Parmar, Vani, MBBS, Regan, Meredith M, ScD, Pagani, Olivia, MD, Fleming, Gini F, MD, Francis, Prudence A, MD, Price, Karen N, BS, Coates, Alan S, MD, Gelber, Richard D, PhD, Goldhirsch, Aron, MD, Walley, Barbara A, MD

“…Summary Background The combined efficacy analysis of the TEXT and SOFT trials showed a significant disease-free survival benefit with exemestane plus ovarian…”
Get full text

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy by Ribi, Karin, Luo, Weixiu, Walley, Barbara A., Burstein, Harold J., Chirgwin, Jacquie, Ansari, Rafat H., Salim, Muhammed, van der Westhuizen, Andre, Abdi, Ehtesham, Francis, Prudence A., Chia, Stephen, Harvey, Vernon J., Giobbie-Hurder, Anita, Fleming, Gini F., Pagani, Olivia, Di Leo, Angelo, Colleoni, Marco, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg

“…Purpose Sexual dysfunction is an important concern of premenopausal women with early breast cancer. We investigated predictors of sexual problems in two…”
Get full text

Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial by Meier-Girard, Delphine, Ribi, Karin, Gerstenberg, Gisa, Ruhstaller, Thomas, Wolf, Ursula

“…Cancer-related fatigue (CRF) is the most taxing symptom for many breast cancer patients during and after therapy. In patients with metastatic disease, the…”
Get full text

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer by Pagan, Eleonora, Ruggeri, Monica, Bianco, Nadia, Bucci, Eraldo Oreste, Graffeo, Rossella, Borner, Markus, Giordano, Monica, Gianni, Lorenzo, Rabaglio, Manuela, Freschi, Andrea, Cretella, Elisabetta, Seles, Elena, Farolfi, Alberto, Simoncini, Edda, Ciccarese, Mariangela, Rauch, Daniel, Favaretto, Adolfo, Honecker, Friedemann, Berardi, Rossana, Franzetti-Pellanda, Alessandra, Gelber, Shari, Partridge, Ann H., Goldhirsch, Aron, Bagnardi, Vincenzo, Pagani, Olivia, Ribi, Karin

“…Although younger age has been negatively associated with persistence to adjuvant endocrine therapy (ET), factors contributing to non-persistence remain poorly…”
Get full text

Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16) by Ribi, Karin, Thürlimann, Beat, Schär, Corinne, Dietrich, Daniel, Cathomas, Richard, Zürrer-Härdi, Ursina, von Briel, Thomas, Anchisi, Sandro, Bohanes, Pierre, Blum, Veronika, von Burg, Philippe, Mannhart, Meinrad, Caspar, Clemens B, von Moos, Roger, Mark, Michael

“…Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care…”
Get full text

When do patient reported quality of life indicators become prognostic in breast cancer? by Lee, Chee Khoon, Hudson, Malcolm, Simes, John, Ribi, Karin, Bernhard, Jürg, Coates, Alan S

“…Various patient reported quality-of-life indicators are independently prognostic for survival in metastatic breast cancer and other cancers. The same measures…”
Get full text

Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review by Colomer-Lahiguera, Sara, Bryant-Lukosius, Denise, Rietkoetter, Sarah, Martelli, Lorraine, Ribi, Karin, Fitzpatrick-Lewis, Donna, Sherifali, Diana, Orcurto, Angela, Juergens, Rosalyn, Eicher, Manuela

“…Context Immune-checkpoint inhibitors (ICI) have shown significant benefits for overall survival across various cancer types. Patient-reported outcomes (PROs)…”
Get full text

Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment by Bana Marika, Ribi Karin, Peters, Solange, Kropf-Staub, Susanne, Näf Ernst, Zürcher-Florin Sabin, Stoffel, Barbara, Blaeuer Cornelia, Borner, Markus, Malin, Diana, Biber, Rebecca, Betticher, Daniel, Kuhn-Bächler Trudy, Cantoni, Nathan, Seeger, Thomas, Bütikofer Lukas, Eicher Manuela

“…BackgroundThe Symptom Navi Program (SNP) is a nurse-led intervention supporting basic symptom self-management for patients with any cancer diagnosis. The SNP…”
Get full text

Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods by Hitz, Felicitas, Ribi, Karin, Grote, Gudela, Kolbe, Michaela, Schmitz, Christof, Lamb, Benjamin W., Ruhstaller, Thomas, Berchtold, Peter, Sevdalis, Nick

“…Background Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is…”
Get full text

Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial by Kappos, Elisabeth A, Schulz, Alexandra, Regan, Meredith M, Moffa, Giusi, Harder, Yves, Ribi, Karin, Potter, Shelley, Pusic, Andrea L, Fehr, Mathias K, Hemkens, Lars G, Holzbach, Thomas, Farhadi, Jian, Simonson, Colin, Knauer, Michael, Verstappen, Ralph, Bucher, Heiner C, Zwahlen, Daniel, Zimmermann, Frank, Schwenkglenks, Matthias, Mucklow, Rosine, Shaw, Jane, Bjelic-Radisic, Vesna, Chiorescu, Amelia, Chun, Yoon S, Farah, Subrina, Xiaosong, Chen, Nigard, Linda, Kuemmel, Sherko, Reitsamer, Roland, Hauschild, Maik, Fulco, Ilario, Tausch, Christoph, Fischer, Thomas, Sarlos, Dimitri, Constantinescu, Mihai A, Lupatsch, Judith E, Fitzal, Florian, Heil, Joerg, Matrai, Zoltan, de Boniface, Jana, Kurzeder, Christian, Haug, Martin, Weber, Walter P

“…IntroductionThe emphasis on aesthetic outcomes and quality of life (QoL) has motivated surgeons to develop skin-sparing or nipple-sparing mastectomy (SSM/ NSM)…”
Get full text

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial by Ribi, Karin, Luo, Weixiu, Colleoni, Marco, Karlsson, Per, Chirgwin, Jacquie, Aebi, Stefan, Jerusalem, Guy, Neven, Patrick, Di Lauro, Vincenzo, Gomez, Henry L., Ruhstaller, Thomas, Abdi, Ehtesham, Biganzoli, Laura, Müller, Bettina, Barbeaux, Annelore, Graas, Marie-Pascale, Rabaglio, Manuela, Francis, Prudence A., Foukakis, Theodoros, Pagani, Olivia, Graiff, Claudio, Vorobiof, Daniel, Maibach, Rudolf, Di Leo, Angelo, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg

“…Background In the phase III SOLE trial, the extended use of intermittent versus continuous letrozole for 5 years did not improve disease-free survival in…”
Get full text

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial by Ribi, Karin, Luo, Weixiu, Colleoni, Marco, Karlsson, Per, Chirgwin, Jacquie, Aebi, Stefan, Jerusalem, Guy, Neven, Patrick, Di Lauro, Vincenzo, Gomez, Henry L., Ruhstaller, Thomas, Abdi, Ehtesham, Biganzoli, Laura, Müller, Bettina, Barbeaux, Annelore, Graas, Marie-Pascale, Rabaglio, Manuela, Francis, Prudence A., Foukakis, Theodoros, Pagani, Olivia, Graiff, Claudio, Vorobiof, Daniel, Maibach, Rudolf, Di Leo, Angelo, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text

Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16) by Mark, Michael, Thürlimann, Beat, Ribi, Karin, Schär, Corinne, Dietrich, Daniel, Cathomas, Richard, Zürrer-Härdi, Ursina, von Briel, Thomas, Anchisi, Sandro, Bohanes, Pierre, Blum, Veronika, von Burg, Philipp, Mannhart, Meinrad, Caspar, Clemens B, von Moos, Roger

“…•Implementation of guideline-recommended BTA practice is high among Swiss physicians.•Denosumab is the BTA of choice in Switzerland.•BTAs were widely…”
Get full text